Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Journal of Biomolecular Screening
|
June 3, 2009
High-quality cost-effective compound management support for HTS
Maximiliano Zaragoza-Sundqvist, Hans Eriksson, Mattias Rohman, et al.
Current Medical Research and Opinion
|
July 10, 2018
Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies
John W Newcomer, Hans Eriksson, Peter Zhang, et al.
Psychopharmacology Bulletin
|
October 15, 2016
A Randomized, Double-blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder
Gang Wang, Alexander McIntyre, Willie R Earley, et al.
The International Journal of Neuropsychopharmacology
|
December 4, 2018
Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale
Mary Hobart, Peter Zhang, Catherine Weiss, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 27, 2014
Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder
Michael Bauer, Michael E Thase, Sherry Liu, et al.
Journal of Affective Disorders
|
October 2, 2010
A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder
Michael Bauer, Nizar El-Khalili, Catherine Datto, et al.
CNS Spectrums
|
August 12, 2009
Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study
Richard Weisler, Mark Joyce, Lora McGill, et al.
Journal of Clinical Psychopharmacology
|
June 23, 2011
A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder
Arifulla Khan, Mark Joyce, Sarah Atkinson, et al.
The Journal of Clinical Psychiatry
|
October 3, 2019
Changes in Metabolic Parameters and Body Weight in Patients With Major Depressive Disorder Treated With Adjunctive Brexpiprazole: Pooled Analysis of Phase 3 Clinical Studies
John W Newcomer, Hans Eriksson, Peter Zhang, et al.
The Journal of Clinical Psychiatry
|
May 13, 2014
Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies
Richard Weisler, Stuart A Montgomery, Willie R Earley, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Journal of Biomolecular Screening
|
June 3, 2009
High-quality cost-effective compound management support for HTS
Maximiliano Zaragoza-Sundqvist, Hans Eriksson, Mattias Rohman, et al.
Current Medical Research and Opinion
|
July 10, 2018
Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies
John W Newcomer, Hans Eriksson, Peter Zhang, et al.
Psychopharmacology Bulletin
|
October 15, 2016
A Randomized, Double-blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder
Gang Wang, Alexander McIntyre, Willie R Earley, et al.
The International Journal of Neuropsychopharmacology
|
December 4, 2018
Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale
Mary Hobart, Peter Zhang, Catherine Weiss, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 27, 2014
Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder
Michael Bauer, Michael E Thase, Sherry Liu, et al.
Journal of Affective Disorders
|
October 2, 2010
A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder
Michael Bauer, Nizar El-Khalili, Catherine Datto, et al.
CNS Spectrums
|
August 12, 2009
Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study
Richard Weisler, Mark Joyce, Lora McGill, et al.
Journal of Clinical Psychopharmacology
|
June 23, 2011
A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder
Arifulla Khan, Mark Joyce, Sarah Atkinson, et al.
The Journal of Clinical Psychiatry
|
October 3, 2019
Changes in Metabolic Parameters and Body Weight in Patients With Major Depressive Disorder Treated With Adjunctive Brexpiprazole: Pooled Analysis of Phase 3 Clinical Studies
John W Newcomer, Hans Eriksson, Peter Zhang, et al.
The Journal of Clinical Psychiatry
|
May 13, 2014
Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies
Richard Weisler, Stuart A Montgomery, Willie R Earley, et al.
Page
of 6